Mohsen Farsad* Pages 1 - 9 ( 9 )
Background. Accurate staging is crucial for the proper management of patients with non-small cell lung cancer, especially for choosing the best treatment strategy. Different Imaging methods are used to stage patients with non-small-cell lung cancer. In the last two decades FDG PET/CT is carried out in almost all main Hospitals around the world in this setting.
Objective. The aim of this paper is to focus on the value of integrated FDG PET/CT in the TNM staging of the non-small-cell lung cancer.
Methods. A non-systematic revision of the literature was performed in order to identify all papers about the role of FDG PET/CT in the evaluation of lung cancer and to highlight the value of FDG PET/CT in this setting.
Results. Many data are now available about this topic, including also randomized controlled trials. FDG PET/CT is of limited added value in the characterization of T status but increases the diagnostic accuracy for the assessment of the nodal status. The main advantages of FDG PET/CT over conventional imaging methods is its higher sensitivity in identifying extra-thoracic metastases, especially bone and adrenal lesions.
Conclusion. PET/CT with FDG should be included in the diagnostic work-up of patients with lung cancer, because it provides information useful for an appropriate therapy.
lung cancer, PET/CT, FDG, staging, therapy, diagnostic work-up, Imaging.
Central Hospital Bolzano/Bozen